Impact of education and clinic site champion on extragenital testing for sexually transmitted infections

Abstract

Background

Sexually transmitted infections (STIs) are on the rise in the United States. Infections at extragenital (EG) sites (throat or rectum) may serve as an overlooked reservoir for STIs. The aims of this project were to determine the proportion of patients receiving EG testing and to observe the impact of an educational intervention.

Methods

Phase I included four urgent care clinics and baseline data for adults receiving STI testing (Chlamydia trachomatis and Neisseria gonorrhoeae). Clinics received access to an educational presentation regarding the importance of EG testing. Two of these clinics served as pilot sites for the implementation of self-collection kits. Phase II involved further expansion and utilization of clinic site champions.

Results

Phase I baseline data indicated that less than 1% of samples from patients receiving STI testing were from EG sites. There was an increase in EG testing after the educational intervention and implementation of self-collection kits. A larger increase in EG testing was seen after utilization of a site champion in Phase II.

Conclusion

EG infections serve as a potential source for STI transmission which makes multi-site testing necessary. Our interventions to improve EG testing were most effective in Phase II after implementing a clinic site champion.

Keywords

Sexually transmitted diseases chlamydia gonorrhea chlamydia infections

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention . Sexually transmitted diseases data and statistics 2021. https://www.cdc.gov/std/statistics/default.htm

Centers for Disease Control and Prevention . Impact of COVID-19 on STDs. https://www.cdc.gov/std/statistics/2021/impact.htm

Soni

White

. Self-screening for Neisseria gonorrhoeae and Chlamydia trachomatis in the human immunodeficiency virus clinic-high yields and high acceptability. Sex Transm Dis 2011; 38(12): 1107–1109.

Calas

Zemali

Camuset

, et al. Prevalence of urogenital, anal, and pharyngeal infections with Chlamydia trachomatis, Neisseria gonorrhoeae, and mycoplasma genitalium: a cross-sectional study in reunion Island. BMC Infect Dis 2021; 21(1): 95–100.

Chan

Robinette

Montgomery

, et al. Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the Literature. Infect Dis Obstet Gynecol 2016; 2016: 5758387.

Trebach

Chaulk

Page

, et al. Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures. Sex Transm Dis 2015; 42(5): 233–239.

Bamberger

Graham

Dennis

, et al. Extragenital gonorrhea and Chlamydia among men and women according to type of sexual exposure. Sex Transm Dis 2019; 46(5): 329–334.

Cohen

. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 1998; 351(Suppl 3): 5–7.

Mitchell

Prabhu

. Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin 2013; 27(4): 793–809.

10.

Alexander

Ison

Parry

, et al. Self-taken pharyngeal and rectal swabs are appropriate for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in asymptomatic men who have sex with men. Sex Transm Infect 2008; 84(6): 488–492.

11.

Yared

Horvath

Fashanu

, et al. Optimizing screening for sexually transmitted infections in men using self-collected swabs: a systematic review. Sex Transm Dis 2018; 45(5): 294–300.